NEW PATENTS

New patents  

END march 2018

8 new patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	WO-2018053057	RELEBACTAM	MERCK	Bacterial infection
2	WO-2018051280	RIBOCICLIB	REDDYS	Metastatic breast cancer
3	WO-2018051237	CARFILZOMIB	FRASENIUS	Multiple myeloma
4	WO-2018051042	AGOMELATINE	Les Laboratoires Servier	DEPRESSION
5	WO-2018049836	PIMAVANSERIN	SHANGHAI	Psychotic disorder
6	WO-2018049634	VENETOCLAX	SOLIPHARMA	CANCER
7	WO-2018049632	OZANIMOD	SOLIPHARMA	Adult respiratory distress syndrome; Arthritis; Multiple sclerosis; Transplant rejection; Ulcerative colitis
8	WO-2018049733	EPSILON CAPROLACTONE	SOUTH CHINA	MRSA infection

19 march 2018 New patents

19 march 2018

7 new patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	WO-2018048871	SOLRIAMFETOL	JAZZ	Cataplexy; Depression; Drug dependence; Hypersomnia; Narcolepsy; Sexual dysfunction
2	WO-2018047131	ELUXADOLINE	SUN	Irritable bowel syndrome
3	WO-2018046401	BETRIXABAN	SANDOZ	Phlebothrombosis
4	WO-2018046337	INGENOL	INDENA	Keratosis
5	WO-2018045997	SOFOSBUVIR	CHIA	Hepatitis C virus infection
6	WO-2018045889	ORITAVANCIN	JHEJIANG	Angina; Bacterial skin infection; Enterococcus faecalis infection; Gram positive bacterium infection; MRSA infection; Streptococcus agalactiae infection; Streptococcus pyogenes infection
7	WO-2018045505	SACUBITRIL	NORATECH	Cardiac failure; Hypertension; Myocardial disease
8	WO-2018048977	ELECLAZINE	AUSPEX	Acute coronary syndrome; Angina; Cancer; Congestive heart failure; Diabetes mellitus; Inflammatory disease; Ischemic heart disease; Myocardial infarction

12 March new patents

12 march 2018

6 new patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	WO-2018042393	BRIVARACETAM	MICROLABS	Epilepsy; Partial seizure
2	WO-2018042320	BETRIXABAN	REDDYS	Phlebothrombosis
3	WO-2018040065	VALSARTAN	NORATECH	Fibrosis; Hypertension; Non-insulin dependent diabetes; Obesity; Renal disease
4	WO-2018039923	DIOSMIN	CHENGDU	Hemorrhoids; Lymphedema; Microangiopathy; Premenstrual syndrome; Ulcer
5	WO-2018041639	VILDAGLIPTIN	UNIV OF BIELEFELD	Non-insulin dependent diabetes
6	WO-2018045043	CENICRIVIROC	TOBIRA	Fibrosis; Non alcoholic fatty liver disease; Non-alcoholic steatohepatitis

5 TH MARCH NEW PATENTS

END FEB, start march 2018

11 new patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	EP-03287467	OBETICHOLIC ACID	RATIOPHARM	Liver disease; Primary biliary cirrhosis
2	WO-2018039521	CENICRIVIROC	CONCERT	Bladder cancer; HIV infection; Head and neck tumor; Hodgkins disease; Melanoma;
3	WO-2018038680	OLAPARIB	SCINOPHARM	Breast tumor; Fallopian tube cancer;
4	WO-2018038426	EDOXABAN	DONG	Deep vein thrombosis
5	WO-2018037423	FLUNISOLIDE	CORAL	Allergic rhinitis; Inflammatory disease
6	WO-2018037350	LUMACAFTOR	LAURUS	Cystic fibrosis
7	WO-2018037124	AVIBACTAM	SANDOZ	ANTIBACTERIAL
8	WO-2018036982	URSODEOXYCHOLIC ACID	PHARMAZELL	Cholelithiasis; Hepatitis;
9	WO-2018036558	DAROLUTAMIDE	CRYSTAL	Hormone dependent prostate cancer;
10	WO-2018036557	LENALIDOMIDE	ZHEJIANG	Adult T-cell lymphoma; Mantle cell lymphoma; Myelodysplastic syndrome
11	WO-2018036416	EFINACONAZOLE	TROPHARMAN	Fungal infection; Onychomycosis